ICICI Prudential Nifty Pharma ETF
ICICI Prudential Mutual Fund · Equity ETFs · Regular Growth · AMFI 154804 · ISIN INF109K1A716
NAV₹28.374820 Nov 2026
3Y return—a year
5Y return—a year
Expense ratio5.70%₹6 Cr
Growth Score—
Returns
| 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 7Y | 10Y | Since launch |
| Fund | +10.14% | — | — | — | — | — | — | — | — | +10.14% |
| NIFTY Pharma TRI | +10.82% | +7.43% | +14.54% | +25.40% | +25.57% | +22.02% | +16.60% | — | — | — |
| Category middle | +9.44% | +2.23% | +7.03% | +1.53% | +0.66% | +11.16% | +8.98% | +12.69% | +13.37% | — |
Risk (36 months)
| Volatility | — |
| Sharpe | — |
| Sortino | — |
| Beta | — |
| Alpha | — |
| Deepest fall | -2.74% |
| 1-year periods with a loss | — |
| 5Y SIP XIRR | — |
Top holdings (31 Oct 2026)
| Sun Pharmaceutical Industries Ltd. | 18.62% |
| Divi's Laboratories Ltd. | 12.29% |
| Laurus Labs Ltd. | 9.27% |
| Dr. Reddy's Laboratories Ltd. | 8.15% |
| Cipla Ltd. | 7.67% |
| Torrent Pharmaceuticals Ltd. | 6.71% |
| Lupin Ltd. | 4.83% |
| Aurobindo Pharma Ltd. | 4.60% |
| Glenmark Pharmaceuticals Ltd. | 3.42% |
| Zydus Lifesciences Ltd. | 3.05% |
| Alkem Laboratories Ltd. | 3.05% |
| Mankind Pharma Ltd. | 2.79% |
Sectors
| Pharmaceuticals & Biotechnology | 100.0% |
Calculated by Growth Analyser from AMFI NAVs and the fund house's disclosed portfolio. Up to 1 year: total return; longer: CAGR. Research and education only; not investment advice. Mutual fund investments are subject to market risks; read all scheme-related documents carefully. Past performance does not indicate future returns.